Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial

The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shiliang Liu, Liling Luo, Lei Zhao, Yujia Zhu, Hui Liu, Qiaoqiao Li, Ling Cai, Yonghong Hu, Bo Qiu, Li Zhang, Jingxian Shen, Yadi Yang, Mengzhong Liu, Mian Xi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:036e46d12f2c46d4b935d155a3a4956f
record_format dspace
spelling oai:doaj.org-article:036e46d12f2c46d4b935d155a3a4956f2021-12-02T16:10:52ZInduction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial10.1038/s41467-021-24288-12041-1723https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24288-1https://doaj.org/toc/2041-1723The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients with unresectable esophageal squamous cell carcinoma.Shiliang LiuLiling LuoLei ZhaoYujia ZhuHui LiuQiaoqiao LiLing CaiYonghong HuBo QiuLi ZhangJingxian ShenYadi YangMengzhong LiuMian XiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Shiliang Liu
Liling Luo
Lei Zhao
Yujia Zhu
Hui Liu
Qiaoqiao Li
Ling Cai
Yonghong Hu
Bo Qiu
Li Zhang
Jingxian Shen
Yadi Yang
Mengzhong Liu
Mian Xi
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
description The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve the response rate or survival of patients with unresectable esophageal squamous cell carcinoma.
format article
author Shiliang Liu
Liling Luo
Lei Zhao
Yujia Zhu
Hui Liu
Qiaoqiao Li
Ling Cai
Yonghong Hu
Bo Qiu
Li Zhang
Jingxian Shen
Yadi Yang
Mengzhong Liu
Mian Xi
author_facet Shiliang Liu
Liling Luo
Lei Zhao
Yujia Zhu
Hui Liu
Qiaoqiao Li
Ling Cai
Yonghong Hu
Bo Qiu
Li Zhang
Jingxian Shen
Yadi Yang
Mengzhong Liu
Mian Xi
author_sort Shiliang Liu
title Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
title_short Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
title_full Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
title_fullStr Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
title_full_unstemmed Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
title_sort induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase ii trial
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/036e46d12f2c46d4b935d155a3a4956f
work_keys_str_mv AT shiliangliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT lilingluo inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT leizhao inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT yujiazhu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT huiliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT qiaoqiaoli inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT lingcai inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT yonghonghu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT boqiu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT lizhang inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT jingxianshen inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT yadiyang inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT mengzhongliu inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
AT mianxi inductionchemotherapyfollowedbydefinitivechemoradiotherapyversuschemoradiotherapyaloneinesophagealsquamouscellcarcinomaarandomizedphaseiitrial
_version_ 1718384390871973888